NIH Research Evaluation and Commercialization Hubs (REACH)
The NIH REACH program will fund five new academic hubs to help move promising biomedical research into real-world products by providing early funding, resources, and mentorship for commercialization and entrepreneurship.
Funder: National Institutes of Health
Due Dates (Anticipated): November 2026 (Full application deadline, projected)
Funding Amounts: Estimated total program funding: $5,000,000; ~5 awards expected
Summary: Supports academic hubs to accelerate commercialization of promising biomedical technologies through funding, mentorship, and entrepreneurship training.
Key Information: This is a forecasted opportunity; application details are not yet available.
Description
The NIH Research Evaluation and Commercialization Hubs (REACH) program is designed to support the translation of innovative biomedical discoveries from academic research into products that improve patient care and public health. Through this forecasted opportunity, NIH plans to fund five new academic entrepreneurship hubs that will provide early-stage funding, technical and business resources, and mentorship to researchers developing high-priority biomedical technologies. The hubs will form a national consortium to identify promising technologies, support feasibility and proof-of-concept studies, and provide access to expertise in science, regulation, business, and law. The program emphasizes public-private partnerships and non-federal matching funds, and aims to strengthen the biomedical innovation ecosystem, workforce development, and address local health needs, especially in underserved or rural areas.
